Riyad Capital Updates Dr. Sulaiman Al Habib Medical Services Group Rating Post-Q3 Results

05:57 AM EDT, 10/27/2026 (MT Newswires) -- Riyad Capital raised its rating on Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) as it took note of the medical group's third-quarter results in a Monday first-look note. For the three-month period, the company's net profit rose 13% annually to 682 million Saudi riyals, which aligned with Riyad Capital's 672 million-riyal forecast. Revenue, meanwhile, increased 18% year over year to 4.10 billion riyals, in line with the research firm's estimate of 4.08 billion riyals. "Margins in 3Q26 increased slightly, reflecting a gradual move towards optimal utilization of the added capacity. However, Tabuk Hospital, which is expected to commence operations in 2027, may put pressure on margins during the initial operating phases. Accordingly, we maintain our target price and raise our recommendation to Buy, as we believe the recent decline in the share price represents an attractive entry opportunity, with the positive long-term outlook supported by the expansion plans," analysts said. The stock has a price target of 260 riyals.